C-Bridge Capital
Cambridge Capital is a private equity fund focused on investing in the health care industry.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed C-Bridge Capital Information
Geographic Data
Address: 45F,Tower 2, Plaza 66,1266 Nanjing Xi Lu
City: Jing'an
State: shanghai municipality
Zip: 200040
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$3B
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Cambridge Capital is a private equity fund focused on investing in the health care industry. It is principally engaged in the development of advanced and M &a; A investments, covering all major health areas such as medicine, medical equipment and medical services. Over the past few years, Cambridge Capital has successfully completed investment projects covering a number of medical and health segments such as biopharmaceuticals, drug distribution, molecular diagnostics and medical devices. Cambridge Capital is designed to accelerate the development and marketization of modern medical and medical technology through the use of capital to improve the health of the whole people and benefit mankind.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2022 | Yaneng Biotechnology | Venture Round | - |
| 3/2017 | I-Mab Biopharma | Series B | 0 |
| 3/2016 | FitSAMO | Series A | - |
| 9/2015 | Ascletis | Series B | 0 |
| 10/2016 | I-Mab Biopharma | Series A | - |
| 1/2017 | Ascletis | Series B | 0 |
| 2/2015 | FitSAMO | Angel Round | - |
| 4/2022 | Yaneng Biotechnology | Venture Round | - |
| 3/2017 | I-Mab Biopharma | Series B | 0 |
| 1/2017 | Ascletis | Series B | 0 |
| 10/2016 | I-Mab Biopharma | Series A | - |
| 3/2016 | FitSAMO | Series A | - |
| 9/2015 | Ascletis | Series B | 0 |
| 2/2015 | FitSAMO | Angel Round | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
